Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06214286
Other study ID # BUCN1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 20, 2024
Est. completion date July 1, 2024

Study information

Verified date March 2024
Source Cairo University
Contact Mina Wahba, PhD
Phone 01285170876
Email mina.magdy@buc.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PURPOSE: To investigate the effect of adding Shock wave therapy to kinesio taping on relieving carpal tunnel syndrome symptoms in physical therapist females. BACKGROUND: shockwave therapy is a popular non-invasive therapeutic modality in the medical field for the treatment of numerous musculoskeletal disorders. Shockwaves can generate interstitial and extracellular responses, producing many beneficial effects such as: pain relief, vascularization, protein biosynthesis, cell proliferation, neuro and chondroprotection, and destruction of calcium deposits in musculoskeletal structures. shockwave combined with conventional physiotherapy is an effective noninvasive treatment for mild-to-moderate carpal tunnel syndrome that produces greater and longer-lasting results than conventional physiotherapy alone HYPOTHESES: Adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females. RESEARCH QUESTION: Does adding Shock wave therapy to kinesio taping has positive effects on carpal tunnel syndrome in physical therapist females?


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - Patients aged between 20 and 40 years - diagnosed as having mild and moderate carpal tunnel syndrome through clinical parameters and nerve conduction studies (NCSs), Exclusion Criteria: - Having any systemic diseases such as renal failure, peptic ulcer, diabetes mellitus, hypothyroidism, coagulopathy, inflammatory rheumatic disease, having a cardiac pacemaker, cervical radiculopathy, polyneuropathy or brachial plexopathy, systemic corticosteroid use, fracture or trauma history in the forearm and wrist pregnancy and lactation, having received a carpal tunnel syndrome surgery, thoracic outlet syndrome or severe carpal tunnel syndrome.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Shockwave
Shockwave therapy
Other:
Kinesio taping
Kinesio taping application
conventional physical therapy
conventional physical therapy

Locations

Country Name City State
Egypt Badr University in Cairo (BUC) Cairo

Sponsors (2)

Lead Sponsor Collaborator
Cairo University Badr University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Visual Analog Scale It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured 1 and 12 week
Secondary Numbness Visual Analog Scale It is self reported outcome, which is a 10 cm line with zero at one end indicating no numbness and 10 at the other end indicating maximum numbness.Patient will be asked to mark the current numbness on the scale, and the distance from the starting point (0) will be measured 1 and 12 week
Secondary Boston Carpal Tunnel Questionnaire a Questionnaire widely used for assessing function and/or symptoms in patients with carpal tunnel syndrome. It consists of two separate scales: the Symptom Severity Scale (SSS), which consists of 11 questions and the Functional Status Scale (FSS), which consists of 8 items and requires respondents to score the difficulty of each item on a five-point scale. A final score is calculated for each scale (the sum of the individual scores divided by the number of items) and ranges from 1 to 5, with a higher score indicating a more severe handicap. 1 and 12 week
Secondary handgrip strength hand grip strength will be measured by a hand held dynamometer Participants will be instructed to grip the dynamometer as strongly as they possibly can, using their affected hand. Three measurements will be taken and the highest value will be used in the analysis 1 and 12 week
Secondary electrodiagnostic study for median nerve Sensory distal latency and motor distal latency of the median nerve will be measured by electromyography device according to standard protocol ( sensory distal latency stimulated at wrist and recorded 14cm at middle finger) and motor distal latency was stimulated at wrist and recorded from abductor pollicis brevis muscle. 1 and 12 week
See also
  Status Clinical Trial Phase
Recruiting NCT05775562 - Early Pulmonary Effects of Excursion Deep Diving With Closed-circuit Gas Recycling: SPIDD Study N/A
Terminated NCT02004015 - Assessment Study of the Effect of NMBA on Bowel Peristalsis Phase 4
Recruiting NCT05859191 - Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus
Recruiting NCT04959435 - Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)